{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:03:45Z","timestamp":1794330225508,"version":"4.9.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:p>Mixed gestational trophoblastic tumors are exceptionally rare and have variable clinicopathological presentations. We report 3 such tumors with different combinations of choriocarcinoma (CC), placental site trophoblastic tumor (PSTT), and epithelioid trophoblastic tumor (ETT). The patients\u2019 age ranged from 38 to 44 years. Mixed trophoblastic tumor was not considered at the initial diagnosis and all 3 tumors were proven of gestational origin by DNA genotyping. Patient #1 presented with serum human chorionic gonadotropin (hCG) of 97 mIU\/mL and a 5.6-cm cervical mass that was initially interpreted as PSTT on biopsy. Hysterectomy revealed a mixed PSTT (60%) and ETT (40%) with extrauterine metastases of only the ETT component. The tumor recurred 15 months after a multiagent chemotherapy and was tested positive for programmed death-ligand 1. The patient received immune checkpoint inhibitor therapy and remained disease-free after 24 months. Patient #2 presented with vaginal bleeding and serum hCG of 46,458 mIU\/mL. An endometrial biopsy was interpreted as CC. Recurrence developed in the uterus and lung after methotrexate-based chemotherapy. A mixed CC and ETT were eventually diagnosed upon consultation review. Patient #3 presented with a complete hydatidiform mole and serum hCG of 744,828 mIU\/mL. Three months after methotrexate, followed by actinomycin D therapy, a uterine mass was found. Hysterectomy revealed a mixed CC and PSTT. In conclusion, the rarity, elusive presentation, and wide range of histology make the diagnosis of mixed trophoblastic tumors highly challenging. The clinical management and prognosis are dictated by each component of the tumor. CC component must be considered when the patient presents with a high serum hCG level.<\/jats:p>","DOI":"10.1097\/pgp.0000000000001044","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T19:00:15Z","timestamp":1720033215000},"page":"42-48","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Mixed Gestational Trophoblastic Tumors\u2014Challenging Clinicopathological Presentations"],"prefix":"10.1097","volume":"44","author":[{"given":"Na","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Buza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,26]]},"reference":[{"key":"R2-20241211","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/00000478-199811000-00010","article-title":"Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma","volume":"22","author":"Shih","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R3-20241211","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/PGP.0000000000000810","article-title":"Coexisting epithelioid trophoblastic tumor and placental site trophoblastic tumor during asymptomatic relapse: a case report and literature review","volume":"41","author":"Aiob","year":"2022","journal-title":"Int J Gynecol Pathol"},{"key":"R4-20241211","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/pgp.0b13e318053df4","article-title":"Primary or secondary? Genotyping confirmation of an ovarian primary carcinoid tumor","volume":"27","author":"Dotto","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R5-20241211","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/his.15054","article-title":"Extrauterine epithelioid trophoblastic tumour and its somatic carcinoma mimics: short tandem repeat genotyping meets the diagnostic challenges","volume":"84","author":"Niu","year":"2023","journal-title":"Histopathology"},{"key":"R6-20241211","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/ijgc-00009577-200205000-00013","article-title":"Mixed choriocarcinoma in a postmenopausal patient","volume":"12","author":"Ramondetta","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"R7-20241211","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1186\/s13104-015-1693-8","article-title":"Placental site trophoblastic tumor and choriocarcinoma: an unusual presentation","volume":"8","author":"Gari","year":"2015","journal-title":"BMC Res Notes"},{"key":"R8-20241211","doi-asserted-by":"crossref","first-page":"e936451","DOI":"10.12659\/AJCR.936451","article-title":"A rare case of combined choriocarcinoma and placental site trophoblastic tumor presenting as skin lesion: a case report","volume":"23","author":"Chatterjee","year":"2022","journal-title":"Am J Case Rep"},{"key":"R9-20241211","first-page":"7254","article-title":"Coexisting epithelioid trophoblastic tumor and placental site trophoblastic tumor of the uterus following a term pregnancy: report of a case and review of literature","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R10-20241211","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1746-1596-8-85","article-title":"Transformation of a post-cesarean section placental site nodule into a coexisting epithelioid trophoblastic tumor and placental site trophoblastic tumor: a case report","volume":"8","author":"Chen","year":"2013","journal-title":"Diagn Pathol"},{"key":"R11-20241211","first-page":"492754","article-title":"A fibroid or cancer? A rare case of mixed choriocarcinoma and epithelioid trophoblastic tumour","volume":"2013","author":"Luk","year":"2013","journal-title":"Case Rep Obstet Gynecol"},{"key":"R12-20241211","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13256-020-02485-8","article-title":"Epithelioid trophoblastic tumor coexisting with choriocarcinoma around an abdominal wall cesarean scar: a case report and review of the literature","volume":"14","author":"Yang","year":"2020","journal-title":"J Med Case Rep"},{"key":"R13-20241211","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.gore.2015.10.002","article-title":"Choriocarcinoma coexisting with epithelioid trophoblastic tumor of the uterine horn","volume":"14","author":"Imamura","year":"2015","journal-title":"Gynecol Oncol Rep"},{"key":"R14-20241211","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.5858\/2003-127-e291-CETTAC","article-title":"Coexisting epithelioid trophoblastic tumor and choriocarcinoma of the uterus following a chemoresistant hydatidiform mole","volume":"127","author":"Shen","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"R15-20241211","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3389\/fonc.2019.01262","article-title":"Diagnosis and management of mixed gestational trophoblastic neoplasia: a study of 16 cases and a review of the literature","volume":"9","author":"Kong","year":"2019","journal-title":"Front Oncol"},{"key":"R16-20241211","doi-asserted-by":"crossref","first-page":"e240606","DOI":"10.1136\/bcr-2020-240606","article-title":"Diagnosis and management of a metastatic mixed gestational trophoblastic neoplasia with synchronous primary lung cancer","volume":"14","author":"Iyengar","year":"2021","journal-title":"BMJ Case Rep"},{"key":"R17-20241211","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/ajcp\/aqy039","article-title":"A case series of five patients with pure or mixed gestational epithelioid trophoblastic tumors and a literature review on mixed tumors","volume":"150","author":"Tse","year":"2018","journal-title":"Am J Clin Pathol"},{"key":"R18-20241211","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/gyno.2002.6583","article-title":"Choriocarcinoma and epithelial trophoblastic tumor: successful treatment of relapse with hysterectomy and high-dose chemotherapy with peripheral stem cell support: a case report","volume":"85","author":"Knox","year":"2002","journal-title":"Gynecol Oncol"},{"key":"R19-20241211","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/GCO.0000000000000674","article-title":"Treatment of gestational trophoblastic disease in the 2020s","volume":"33","author":"Clark","year":"2021","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R20-20241211","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/OGX.0000000000000978","article-title":"A review of current management of placental site trophoblastic tumor and epithelioid trophoblastic tumor","volume":"77","author":"Burkett","year":"2022","journal-title":"Obstet Gynecol Surv"},{"issue":"suppl 1","key":"R21-20241211","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1097\/PGP.0000000000000876","article-title":"Dataset for the reporting of gestational trophoblastic neoplasia: recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"41","author":"Hui","year":"2022","journal-title":"Int J Gynecol Pathol"},{"key":"R22-20241211","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/14737140.2023.2215438","article-title":"Management of trophoblastic tumors: review of evidence, current practice, and future directions","volume":"23","author":"Deleuze","year":"2023","journal-title":"Expert Rev Anticancer Ther"},{"key":"R23-20241211","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/PGP.0000000000000305","article-title":"PD-L1 expression in human placentas and gestational trophoblastic diseases","volume":"36","author":"Veras","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"R24-20241211","first-page":"261","article-title":"Age related cellular immune response against complete molar pregnancy","volume":"55","author":"Nagymanyoki","year":"2010","journal-title":"J Reprod Med"},{"key":"R25-20241211","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/bjc.1973.144","article-title":"Cellular reaction in trophoblastic tumours","volume":"28","author":"Elston","year":"1973","journal-title":"Br J Cancer"},{"key":"R26-20241211","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/his.13882","article-title":"PD-L1, B7-H3, and VISTA are highly expressed in gestational trophoblastic neoplasia","volume":"75","author":"Zong","year":"2019","journal-title":"Histopathology"},{"key":"R27-20241211","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.humpath.2018.10.001","article-title":"Analysis of PD-L1 expression in trophoblastic tissues and tumors","volume":"84","author":"Lu","year":"2019","journal-title":"Hum Pathol"},{"key":"R28-20241211","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7150\/jca.28134","article-title":"Epithelioid trophoblastic tumors: treatments, outcomes, and potential therapeutic targets","volume":"10","author":"Yang","year":"2019","journal-title":"J Cancer"},{"key":"R29-20241211","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/IGC.0000000000000892","article-title":"PD-L1 expression in premalignant and malignant trophoblasts from gestational trophoblastic diseases is ubiquitous and independent of clinical outcomes","volume":"27","author":"Bolze","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"R30-20241211","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/S0140-6736(17)32894-5","article-title":"Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia","volume":"390","author":"Ghorani","year":"2017","journal-title":"Lancet"},{"key":"R31-20241211","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000533972","article-title":"Immunotherapy for GTN: a new paradigm","volume":"89","author":"Baas","year":"2023","journal-title":"Gynecol Obstet Invest"},{"key":"R32-20241211","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/modpathol.3800025","article-title":"Comparative genomic hybridization study of placental site trophoblastic tumour: a report of four cases","volume":"17","author":"Hui","year":"2004","journal-title":"Mod Pathol"},{"key":"R33-20241211","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/modpathol.2008.165","article-title":"Epithelioid trophoblastic tumor: comparative genomic hybridization and diagnostic DNA genotyping","volume":"22","author":"Xu","year":"2009","journal-title":"Mod Pathol"},{"key":"R34-20241211","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/modpathol.3800941","article-title":"Absence of Y chromosome in human placental site trophoblastic tumor","volume":"20","author":"Hui","year":"2007","journal-title":"Mod Pathol"},{"key":"R35-20241211","doi-asserted-by":"crossref","first-page":"364508","DOI":"10.1155\/2010\/364508","article-title":"Lack of a y-chromosomal complement in the majority of gestational trophoblastic neoplasms","volume":"2010","author":"Yap","year":"2010","journal-title":"J Oncol"},{"key":"R36-20241211","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ygyno.2016.05.033","article-title":"Molecular genotyping of placental site and epithelioid trophoblastic tumours; female predominance","volume":"142","author":"Zhao","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R37-20241211","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1097\/PAS.0b013e318058a529","article-title":"Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis","volume":"31","author":"Mao","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R38-20241211","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/1097-0142(19890401)63:7<1370::AID-CNCR2820630723>3.0.CO;2-G","article-title":"Metastatic gestational choriocarcinoma. Unusual pathologic variant following therapy","volume":"63","author":"Mazur","year":"1989","journal-title":"Cancer"},{"key":"R39-20241211","doi-asserted-by":"crossref","first-page":"907045","DOI":"10.3389\/fonc.2022.907045","article-title":"A multicenter retrospective study of epithelioid trophoblastic tumors to identify the outcomes, prognostic factors, and therapeutic strategies","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"R40-20241211","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/PGP.0000000000000259","article-title":"Clinicopathologic analysis of postchemotherapy gestational trophoblastic neoplasia: an entity overlapping with epithelioid trophoblastic tumor","volume":"35","author":"Lu","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"R41-20241211","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/1097-0142(19821101)50:9<1833::AID-CNCR2820500930>3.0.CO;2-4","article-title":"Fatal gestational choriocarcinoma. Clinicopathologic study of patients treated at a trophoblastic disease center","volume":"50","author":"Mazur","year":"1982","journal-title":"Cancer"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000001044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T19:36:13Z","timestamp":1733945773000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000001044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,26]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000001044","relation":{},"ISSN":["0277-1691","1538-7151"],"issn-type":[{"value":"0277-1691","type":"print"},{"value":"1538-7151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,26]]}}}